Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey

SOURCE: The Lancet Infectious Diseases
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2022
TITLE AUTHOR(S): S.Moyo, F.Ismail, M.van der Walt, N.Ismail, N.Mkhondo, S.Dlamini, T.Mthiyane, J.Chikovore, O.Oladimeji, D.Mametja, P.Maribe, I.Seocharan, P.Ximiya, I.Law, M.Tadolini, K.Zuma, S.Manda, C.Sismanidis, Y.Pillay, L.Mvusi
KEYWORDS: HEALTH CARE, RISK BEHAVIOUR, TUBERCULOSIS
DEPARTMENT: Equitable Education and Economies (IED), Public Health, Societies and Belonging (HSC)
Print: HSRC Library: shelf number 9812372
HANDLE: 20.500.11910/19445
URI: http://hdl.handle.net/20.500.11910/19445

If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.

Abstract

Tuberculosis remains an important clinical and public health issue in South Africa, which has one of the highest tuberculosis burdens in the world. We aimed to estimate the burden of bacteriologically confirmed pulmonary tuberculosis among people aged 15 years or older in South Africa. This multistage, cluster-based, cross-sectional survey included eligible residents in 110 clusters nationally (cluster size of 500 people; selected by probability proportional-to-population size sampling). Participants completed face-to-face symptom questionnaires (for cough, weight loss, fever, and night sweats) and manually read digital chest X-ray screening. Screening was recorded as positive if participants had at least one symptom or an abnormal chest X-ray suggestive of tuberculosis, or a combination thereof. Sputum samples from participants who were screen-positive were tested by the Xpert MTB/RIF Ultra assay (first sample) and Mycobacteria Growth Indicator Tube culture (second sample), with optional HIV testing. Participants with a positive Mycobacterium tuberculosis complex culture were considered positive for bacteriologically confirmed pulmonary tuberculosis; when culture was not positive, participants with a positive Xpert MTB/RIF Ultra result with an abnormal chest X-ray suggestive of active tuberculosis and without current or previous tuberculosis were considered positive for bacteriologically confirmed pulmonary tuberculosis. Between Aug 15, 2017, and July 28, 2019, 68771 people were enumerated from 110 clusters, with 53250 eligible to participate in the survey, of whom 35191 participated. 9066 of 35191 participants were screen positive and 234 were identified as having bacteriologically confirmed pulmonary tuberculosis. Overall, the estimated prevalence of bacteriologically confirmed pulmonary tuberculosis was 852 cases per 100000 population; the prevalence was highest in people aged 35-44 years per 100000 population) and those aged 65 years or older per 100000 population). The estimated prevalence was approximately 1-6 times higher in men than in women per 100000 population vs 675 cases per 100000 population). 135 of 234 participants with tuberculosis screened positive by chest X-ray only, 16 by symptoms only, and 82 by both. 55 of 191 participants with tuberculosis with known HIV status were HIV-positive Pulmonary tuberculosis prevalence in this survey was high, especially in men. Despite the ongoing burden of HIV, many participants with tuberculosis in this survey did not have HIV. As more than half of the participants with tuberculosis had an abnormal chest X-ray without symptoms, prioritising chest X-ray screening could substantially increase case finding.